Headache in pregnancy

Current Pain and Headache Reports

Volumn 7, Issue 4, 2003, Pages 288-296

  Marcus, Dawn A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AMFEBUTAMONE; ANALGESIC AGENT; ANTIEMETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CODEINE; DIPHENHYDRAMINE; DOPAMINE; ENDORPHIN; ENKEPHALIN; ESTRADIOL RECEPTOR; ESTROGEN; GABAPENTIN; HYDROCODONE; METOCLOPRAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN; OPIATE; PARACETAMOL; PROCHLORPERAZINE; PROMETHAZINE; SEROTONIN; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR; SUMATRIPTAN; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROATE SEMISODIUM; VALPROIC ACID;

ARTERIOVENOUS MALFORMATION; BLOOD ANALYSIS; BRAIN PSEUDOTUMOR; BRAIN TUMOR; CARDIOVASCULAR DISEASE; CELL ACTIVATION; CEREBROSPINAL FLUID ANALYSIS; CEREBROVASCULAR ACCIDENT; CLEFT PALATE; CONCEPTION; CONGENITAL MALFORMATION; CONSERVATIVE TREATMENT; CONSTIPATION; DIET RESTRICTION; DIFFERENTIAL DIAGNOSIS; DRUG ABUSE; DRUG EFFICACY; DUCTUS ARTERIOSUS OBLITERATION; ECLAMPSIA; FEEDBACK SYSTEM; FEEDING BEHAVIOR; FETUS MORTALITY; HEADACHE; HUMAN; INGUINAL HERNIA; MEDICAL DECISION MAKING; MENINX; NERVE CELL; NEURAL TUBE DEFECT; NEUROLOGIC EXAMINATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN THRESHOLD; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PREGNANCY; PREMATURE LABOR; RADIATION EXPOSURE; RELAXATION TRAINING; REVIEW; SAFETY; SECOND TRIMESTER PREGNANCY; SLEEP; SMOKING CESSATION; STRESS; SYMPTOM; TRIGEMINAL NERVE; VASODILATATION; BLOOD; DRUG EFFECT; FEMALE;

ESTROGENS; FEMALE; HEADACHE; HUMANS; PREGNANCY;

EID: 0041909658     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-003-0049-6     Document Type: Review

References (119)

1. Rasmussen BK: Migraine and tension-type headache in a general population: precipitating factors, female hormones, sleep pattern and relation to lifestyle. Pain 1993, 53:65-72.
2. Schwartz BS, Stewart WF, Simon D, Lipton RB: Epidemiology of tension-type headache. JAMA 1998, 279:381-383.
3. Rozen TD, Swanson JW, Stang PE, et al.: Incidence of medically recognized migraine: a 1989-1990 study in Olmstead County, Minnesota. Headache 2000, 40:216-223.
4. Cheung RT: Prevalence of migraine, tension-type headache, and other headaches in Hong Kong. Headache 2000, 40:473-479.
5. Callaghan N: The migraine syndrome in pregnancy. Neurology 1968, 18:197-199.
6. Granella F, Sances G, Zanferrari C, et al.: Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache 1993, 33:385-389.
7. Chen TC, Leviton A: Headache recurrences in pregnant women with migraine. Headache 1994, 34:107-110.
8. Maggioni F, Alessi C, Maggino T, et al.: Primary headaches and pregnancy. Cephalalgia 1995, 15:54.
9. Marcus DA, Scharff L, Turk D: Longitudinal prospective study of headache during pregnancy and postpartum. Headache 1999, 39:625-632.
10. Moskowitz MA: The neurobiology of vascular head pain. Ann Neurol 1984, 16:157-168.
11. Marcus DA: Serotonin and its role in headache pathogenesis and treatment. Clin J Pain 1993, 9:159-167.
12. Marcus DA. Interrelationships of neurochemicals, estrogen, and recurring headache. Pain 1995, 62:129-139.
13. Kruger H, Luhmann HJ, Heinemann U: Repetitive spreading depression causes selective suppression of GABAergic function. Neuroreport 1996, 7:2733-2736.
14. Fanciullaci M, Alessandri M, Del Rosso A: Dopamine involvement in the migraine attack. Funct Neurol 2000, 15:171-181.
15. Hellstrom B, Lundberg U: Pain perception to the cold pressor test during the menstrual cycle in relation to estrogen levels and a comparison with men. Integr Physiol Behav Sci 2000, 35:1377-1379.
16. Zeichner A, Loftin M, Panopoulos G, et al.: Sex differences in pain indices, exercise, and use of analgesics. Psychol Rep 2000, 86:129-133.
17. Unruh AM: Gender variations in clinical pain experience. Pain 1996, 65:123-167.
18. Unruh AM, Ritchie J, Merskey H: Does gender affect appraisal of pain and pain coping strategies? Clin J Pain 1999, 15:31-40.
19. Dawson-Basoa MB, Gintzler AR: 17-Beta-estradiol and progesterone modulate an intrinsic opioid analgesic system. Brain Res 1993, 601:241-245.
20. Cogan R, Spinnato JA: Pain and discomfort thresholds in late pregnancy. Pain 1986, 27:63-68.
21. Heritage AS, Stumpf WE, Sar M, Grant L: Brainstem catecholamine neurons are target sites for sex hormones. Science 1980, 207:1377-1379.
22. Joy KP, Tharakan B, Goos HJ: Distribution of gamma-aminobutyric acid in catfish (Heteropneustes fossilis) forebrain in relation to season, ovariectomy and E2 replacement, and effects of GABA administration on plasma gonadotropin-II level. Comp Biochem Physiol A Mol Integr Physiol 1999, 123:369-376.
23. Lagrange AH, Ronnekleiv OK, Kelly MJ: The potency of muopioid hyperpolarization of hypothalamic arcuate neurons is rapidly attenuated by 17-beta-estradiol. J Neurosci 1994, 14:6196-6204.
24. Amandusson A, Hermanson O, Blomqvist A: Colocalization of oestrogen receptor immunoreactivity and preproenkephalin MRNA expression to neurons in the superficial laminae of the spinal and medullary dorsal horn of rats. Eur J Neurosci 1996, 8:2440-2445.
25. Amandusson A, Hallbeck M, Hallbeck AL, et al.: Oestrogen-induced alterations of spinal cord enkephalin gene expression. Pain 1999, 83:243-248.
26. Fabre-Nys C: Steroid control of monoamines in relation to sexual behavior. Rev Reprod 1998, 3:31-41.
27. Glaser J, Russell VA, Taljaard JJ: Rat brain hypothalamic and hippocampal beta-adrenergic receptor changes during pregnancy. Brain Res 1992, 557:293-299.
28. Bendtsen L: Sensitization: its role in primary headache. Curr Opin Investig Drugs 2002, 3:449-453.
29. Strassman AM, Raymond SA, Burstein R: Sensitization of meningeal sensory neurons and the origin of headaches. Nature 1996, 384:560-564.
30. Burstein R: Deconstructing migraine into peripheral and central sensitization. Pain 2001, 89:107-110.
31. Burstein R, Yarnitsky D, Goor-Aryeh I, et al.: An association between migraine and cutaneous allodynia. Ann Neurol 2000, 47:614-624.
32. Burstein R, Collins B, Bajwa Z, Jakubowski M: Triptan therapy can abort migraine attacks if given before the establishment or in the absence of cutaneous allodynia and central sensitization: clinical and preclinical evidence. Headache 2002, 42:390-391.
33. Edwards HE, Burnham WM, Mendonca A, et al.: Steroid hormones affect limbic afterdischarge threshold and kindling rates in adult female rats. Brain Res 1999, 838:136-150.
34. Hennessy JW, Levin R, Levine S: Influence of experiential factors and gonadal hormones on pituitary-adrenal response of the mouse to novelty and electric shock. J Comp Physiol Psychol 1977, 91:770-777.
35. Hewett TE: Neuromuscular and hormonal factors associated with knee injuries in female athletes: strategies for intervention. Sports Med 2000, 29:313-327.
36. Dumas GA, Reid JG: Laxity of knee cruciate ligaments during pregnancy. J Orthop Sports Phys Ther 1997, 26:2-6.
37. Charlton WP, Coslett-Charlton LM, Ciccotti MG: Correlation of estradiol in pregnancy and anterior cruciate ligament laxity. Clin Orthop 2001, 387:165-170.
38. Blecher AM, Richmond JC: Transient laxity of an anterior cruciate ligament-reconstructed knee related to pregnancy. Arthroscopy 1998, 14:77-79.
39. Ohtera K, Zobitz ME, Luo ZP, et al.: Effect of pregnancy on joint contracture in the rat knee. J Appl Physiol 2002, 92:1494-1498.
40. Karageanes SJ, Blackburn K, Vangelos ZA: The association of the menstrual cycle with the laxity of the anterior cruciate ligament in adolescent female athletes. Clin J Sport Med 2000, 10:162-168.
41. Kristiansson P, Svardsudd K, Von Schoultz B: Serum relaxin, symphyseal pain, and back pain during pregnancy. Am J Obstet Gynecol 1996, 175:1342-1347.
42. Edmeads J: Headache of cervical origin. Rev Prat 1990, 11:40:399-402.
43. Friedman MH, Weisberg J: The craniocervical connection: a retrospective analysis of 300 whiplash patients with cervical and temporomandibular disorders. Cranio 2000, 18:163-167.
44. Jacome DE: Headache in Ehlers-Danlos syndrome. Cephalalgia 1999, 19:791-796.
45. Kumral E, Bogousslavsky J, Van Melle G, et al.: Headache at stroke onset: the Lausanne Stroke Registry. J Neurol Neurosurg Psychiatry 1995, 58:490-492.
46. Ferro JM, Melo TP, Oliveira V, et al.: A multivariate study of headache associated with ischemic stroke. Headache 1995, 35:315-319.
47. Arboix A, Massons J, Oliveres M, et al.: Headache in acute cerebrovascular disease: a prospective clinical study in 240 patients. Cephalalgia 1994, 14:37-40.
48. Cross JN, Castro PO, Jennett WB: Cerebral strokes associated with pregnancy and the puerperium. BMJ 1968, 3:214-218.
49. Wiebers DO, Whisnant JP: Incidence of stroke among pregnant women in Rochester, Minn, 1955-1979. JAMA 1985, 254:3055-3057.
50. Sharshar T, Lamy C, Mas JL: Incidence and causes of strokes associated with pregnancy and puerperium; a study in public hospitals of Ile de France. Stroke 1995, 26:930-936.
51. Kittner SJ, Stern BJ, Feeser BR, et al.: Pregnancy and the risk of stroke. N Engl J Med 1996, 335:768-774.
52. Jaigobin C, Silver FL: Stroke and pregnancy. Stroke 2000, 31:2948-2951.
53. Lamy C, Hamon JB, Coste J, Mas JL: Ischemic stroke in young women: risk of recurrence during subsequent pregnancies. Neurology 2000, 55:269-274.
54. Francois P, Fabre M, Lioret E, Jan M: Vascular cerebral thrombosis during pregnancy and post-partum. Neurochirurgie 2000, 46:105-109.
55. Lanska DJ, Kryscio RJ: Stroke and intracranial venous thrombosis during pregnancy and puerperium. Neurology 1998, 51:1622-1628.
56. Panagariya A, Maru A: Cerebral venous thrombosis in pregnancy and puerperium: a prospective study. J Assoc Physicians India 1997, 45:857-859.
57. Gokcil Z, Odabai Z, Vural O, Tardim M: Cerebral venous thrombosis in pregnancy: the role of protein S deficiency. Acta Neurol Belg 1998, 98:36-38.
58. Burneo JG, Elias SB, Barkley GL: Cerebral venous thrombosis due to protein S deficiency in pregnancy. Lancet 2002, 359:892.
59. Kindu AK: Pregnancy related cerebral venous thrombosis needs exclusion of antiphospholipid syndrome. J Assoc Physicians India 1998, 46:748.
60. Stoodley MA, Macdonald RL, Weir BK: Pregnancy and intracranial aneurysms. Neurosurg Clin N Am 1998, 9:549-556.
61. Horton JC, Chambers WA, Lyons SL, et al.: Pregnancy and the risk of hemorrhage from cerebral arteriovenous malformations. Neurosurgery 1990, 27:867-872.
62. Sadasivan B, Malik GM, Lee C, Ausman JI: Vascular malformations and pregnancy. Surg Neurol 1990, 33:305-313.
63. Fujita K, Tsunoda H, Shigemitsu S, Kubo T: Clinical study on the intracranial arteriovenous malformation associated with pregnancy. Nippon Sanka Funjinka Gakkai Zasshi 1995, 47:1359-1364.
64. Lambe M, Coogan P, Baron J: Reproductive factors and the risk of brain tumors: a population-based study in Sweden. Int J Cancer 1997, 72:389-393.
65. Azpilcueta A, Peral C, Giraldo I, et al.: Meningioma in pregnancy: report of a case and review of the literature. Ginecol Obstet Mex 1995, 63:349-351.
66. Saitoh Y, Oku Y, Izumoto S, Go J: Rapid growth of a meningioma during pregnancy: relationship with estrogen and progesterone receptors: case report. Neurol Med Cir (Tokyo) 1989, 29:440-443.
67. Wan WL, Geller JL, Feldon SE, Sadun AA: Visual loss caused by rapidly progressive intracranial meningiomas during pregnancy. Ophthalmology 1990, 97:18-21.
68. Fujimoto M, Yoshino E, Mizukawa N, Hirakawa K: Spontaneous reduction in size of prolactin-producing adenoma after delivery: case report. J Neurosurg 1985, 63:973-974.
69. Oishi Y, Okuda M, Takahashi H, et al.: Cellular proliferation in the anterior pituitary gland of normal adult rats: influence of sex, estrus cycle, and circadian change. Anat Rec 1993, 235:111-120.
70. Armstrong J, Childs GV: Changes in expression of epidermal growth factor receptors by anterior pituitary cells during the estrous cycle: cyclic expression by gonadotropes. Endocrinology 1997, 138:1903-1908.
71. Heaney AP, Fernanado M, Melmed S: Functional role of estrogen in pituitary tumor pathogenesis. J Clin Invest 2002, 109:277-283.
72. Arseni C, Simoca I, Jipescu I, et al.: Pseudotumor cerebri: risk factors, clinical course, prognostic criteria. Rom J Neurol Psychiatry 1992, 30:115-132.
73. Katz VL, Peterson R, Cefalo RC: Pseudotumor cerebri and pregnancy. Am J Perinatol 1989, 6:442-445.
74. Koontz WL, Herbert WP, Cefalo RC: Pseudotumor cerebri in pregnancy. Obstet Gynecol 1983, 62:324-327.
75. Davis LE: Normal laboratory values of CSF during pregnancy. Arch Neurol 1979, 36:443.
76. Levine D, Barnes PD, Edleman RR: Obstetric MR imaging. Radiology 1999, 211:609-617.
77. Baker P, Johnson I, Harvey P, Mansfield P: A three-year follow-up of children imaged in utero using echo-planar magnetic resonance. Am J Obstet Gynecol 1994, 170:32-33.
78. Kanal E, Gillen J, Evans J, et al.: Survey of reproductive health among female MR workers. Radiology 1993, 187:395-399.
79. ACR standards: MRI safety and sedation. www.acr.org. Accessed September 12, 2002.
80. Marcus DA: Benign recurring headache classification. Clin J Pain 1992, 8:180-184.
81. Baumgartner C, Wessely P, Bingol C, et al.: Long-term prognosis of analgesic withdrawal in patients with drug-induced headache. Headache 1989, 29:510-514.
82. Carp HJ, Fein A, Nebel L: Effect of diclofenac on implantation and embryonic development in the rat. Eur J Obstet Gynecol Reprod Biol 1988, 28:273-277.
83. Kanayama K, Osada H, Nariai K, Endo T: Inhibitory effects of indomethacin on implantation and its related phenomena. J Int Med Res 1996, 24:258-262.
84. Momma K, Hagiwara H, Konishi T: Constriction of fetal ductus arteriosus by non-steroidal anti-inflammatory drugs: study of additional 34 drugs. Prostaglandins 1984, 28:527-536.
85. Rein AJ, Nadjari M, Elchalal U, Nir A: Contraction of the fetal ductus arteriosus induced by diclofenac: case report. Fetal Diagn Ther 1999, 14:24-25.
86. Zenker M, Klinge J, Kruger C, et al.: Severe pulmonary hypertension in a neonate caused by premature closure of the ductus arteriosus following maternal treatment with diclofenac: a case report. J Perinat Med 1998, 26:231-234.
87. Bracken MB, Holford TR: Exposure to prescribed drugs in pregnancy and association with congenital malformations. Obstet Gynecol 1981, 58:336-344.
88. Saxen I: Association between oral cleft and drugs taken during pregnancy. Int J Epidemiol 1975, 4:37-44.
89. Saxen I: Epidemiology of cleft lip and palate: an attempt to rule out chance correlations. Br J Prev Soc Med 1975, 29:103-110.
90. The Merck Manual of Diagnostics and Therapeutics, edn 17, section 15, chapter 195: Drug use and dependence (Available at www.merck.com/pubs. Accessed September 12, 2002).
91. Jones J, Pack S, Chun E: Intramuscular prochlorperazine versus metoclopramide as single-agent therapy for the treatment of acute migraine headache. Ann Emerg Med 1996, 14:262-264.
92. Coppola M, Yealy DM, Leibold RA: Randomized, placebo-controlled evaluation of prochlorperazine versus metochlorpramide for emergency department treatment of migraine headache. Ann Emerg Med 1995, 26:541-546.
93. Schuhaiber S, Patusak A, Schick B, et al.: Pregnancy outcome following first trimester exposure to sumatriptan. Neurology 1998, 51:581-583.
94. O'Quinn S, Ephross SA, Williams V, et al.: Pregnancy and perinatal outcomes in migraineurs using sumatriptan: a prospective study. Arch Gynecol Obstet 1999, 263:7-12.
95. Sumatriptan and Naratriptan pregnancy registry data [on file]. Research Triangle Park, NC: GlaxoSmithKline.
96. Olesen L, Steffensen FH, Sorensen HT, et al.: Pregnancy outcome following prescription for sumatriptan. Headache 2000, 40:20-24.
97. Kallen B, Lygner PE: Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan. Headache 2001, 41:351-356.
98. Bank J: A comparative study of amitriptyline and fluvoxamine in migraine prophylaxis. Headache 1994, 34:476-478.
99. Black KJ, Sheline YI: Paroxetine as migraine prophylaxis. J Clin Psychiatry 1995, 56:330-331.
100. Kulin NA, Pastuszak A, Sage SR, et al.: Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA 1998, 279:609-610.
101. D'Amato CC, Pizza V, Marmolo T, et al.: Fluoxetine for migraine prophylaxis: a double-blind study. Headache 1999, 39:716-719.
102. Amelin AV, Skoromets AA, Korenko KA, et al.: A comparative efficiency of amitriptyline, fluoxetine, and maprotiline in prevention of migraine in attack-free period. Zh Nevrol Psikhiatr Im S S Korsakova 2000, 100:20-23.
103. Goodman JF: Treatment of headache with bupropion. Headache 1997, 37:256.
104. Pinsker W: Potentially safe and effective new treatment for migraine? Headache 1998, 38:58.
105. Thomas SV, Indrani L, Devi GC, et al.: Pregnancy in women with epilepsy: preliminary results of Kerala registry of epilepsy and pregnancy. Neurol India 2001, 49:60-66.
106. Simpkins JW, Field FP, Torosian G, Soltis EE: Effects of prenatal exposure to tricyclic antidepressants on adrenergic responses in progeny. Dev Pharmacol Ther 1985, 8:17-33.
107. Gulmezoglu AM, Hofmeyr GJ: Calcium channel blockers for potential impaired fetal growth. Cochrane Database Syst Rev 2000, 2:CD00049.
108. Sorensen HT, Czeizel AE, Rockenbauer M, et al.: The risk of limb deficiencies and other congenital abnormalities in children exposed in utero to calcium channel blockers. Acta Obstet Gynecol Scand 2001, 80:397-401.
109. Marcus DA: Nonpharmacologic treatment of migraine. TEN 2001, 3:50-55.
110. Cordingley G, Holrody K, Pingel J, et al.: Amitriptyline versus stress management therapy in the prophylaxis of chronic tension headache. Headache 1990, 30:300.
111. French DJ, Holroyd KA, Pinell C, et al.: Perceived self-efficacy and headache-related disability. Headache 2000, 40:647-656.
112. Solbach P, Sargent J, Coyne L: Menstrual migraine headache: results of a controlled, experimental, outcome study of non-drug treatments. Headache 1984, 24:75-78.
113. Gauthier JG, Fournier AL, Roberge C: The differential effects of biofeedback in the treatment of menstrual and nonmenstrual migraine. Headache 1991, 31:82-90.
114. Warner G, Lance JW: Relaxation therapy in migraine and chronic tension headache. Med J Australia 1975, 1:298-301.
115. Daly EJ, Donn PA, Galliher MJ, Zimmerman JS: Biofeedback applications to migraine and tension headache: a double-blinded outcome study. Biofeedback Self Regul 1983, 8:135-152.
116. Blanchard EB, Andrasik F, Appelbaum KA, et al.: The efficacy and cost-effectiveness of minimal-therapist-contact, non-drug treatments of chronic migraine and tension headache. Headache 1985, 25:214-220.
117. Marcus DA, Scharff L, Turk DC: Nonpharmacologic management of headaches during pregnancy. Psychosom Med 1995, 57:527-533.
118. Scharff L, Marcus DA, Turk DC: Maintenance of effects in the nonmedical treatment of headaches during pregnancy. Headache 1996, 36:285-290.
119. Payne TJ, Stetson B, Stevens VM, et al.: Impact of cigarette smoking on headache activity in headache patients. Headache 1991, 31:329-332.